Increased sensivity to infection due to memantine-induced blocking of inlammatory cell trafficking

Memantine is a selective N-methyl-d-aspartate receptor antagonist, used clinically for treating Alzheimer’s disease. The proposed mechanism of action is the blocking of inflammatory cells infiltration into the brain and spinal cord. Previously, we uncovered the potential of memantine to ameliorate symptoms of experimental autoimmune encephalomyelitis (EAE) in old rats [previously published in: Bufan B et al (2024), Biomedicines 12 (4):717]. Here, we have treated female dark agouti rats (3 and 22 months old) with memantine (60 mg/kg body weight) for 7 days (1st–7th day post-immunization for EAE). On the 7th day, we assayed peritoneal and blood leukocytes for their phenotype and functionality. Memantine treatment reduced the expression of the surface major histocompatibility complex class II (MHCII) on peritoneal macrophages. Peritoneal macrophages were weakly responsive to in vitro LPS stimulation. Macrophages from old rats produced more nitric oxide (NO) ex vivo compared to macrophages from young rats. Cellularity of peritoneal cavity was inversely correlated with NO production, however memantine treatment seemed to reverse that correlation in old rats. Peritoneal cells from memantine-treated rats responded differently to phorbol 12-myristate 13-acetate (PMA) – there was an increased dihidrorhodamine fluorescence in all leucokytes, which was abrogated with memantine treatment, and in the old rat group there was a stronger PMA stimulation but reduced inhibitory effect of memantine. Among blood lymphocytes, there was a decreased expression of CD49d (CD43+CD62L+CD49d+), as well as an increased percentage of CD62L+ cells. Finally, while our results show a more pronounced effect of memantine in young rats, we have noticed that old rats under memantine treatment showed signs of nonEAE distress (rough fur, lethargy, respiratory issues). These results show the fast effect of memantine on a systemic level, as well as the potential downsides of its mechanism of action. *The authors marked with an asterisk equally contributed to the work.

Publication Details

Journal
InTOR – Repository of the Institute "Torlak" (Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, Serbia)
Published
2025-01-01
Primary Topic
Geochemistry and Geologic Mapping
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Increased sensivity to infection due to memantine-induced blocking of inlammatory cell trafficking

InTOR – Repository of the Institute "Torlak" (Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, Serbia)
Geochemistry and Geologic Mapping
article

Increased sensivity to infection due to memantine-induced blocking of inlammatory cell trafficking

article en

Abstract

Memantine is a selective N-methyl-d-aspartate receptor antagonist, used clinically for treating Alzheimer’s disease. The proposed mechanism of action is the blocking of inflammatory cells infiltration into the brain and spinal cord. Previously, we uncovered the potential of memantine to ameliorate symptoms of experimental autoimmune encephalomyelitis (EAE) in old rats [previously published in: Bufan B et al (2024), Biomedicines 12 (4):717]. Here, we have treated female dark agouti rats (3 and 22 months old) with memantine (60 mg/kg body weight) for 7 days (1st–7th day post-immunization for EAE). On the 7th day, we assayed peritoneal and blood leukocytes for their phenotype and functionality. Memantine treatment reduced the expression of the surface major histocompatibility complex class II (MHCII) on peritoneal macrophages. Peritoneal macrophages were weakly responsive to in vitro LPS stimulation. Macrophages from old rats produced more nitric oxide (NO) ex vivo compared to macrophages from young rats. Cellularity of peritoneal cavity was inversely correlated with NO production, however memantine treatment seemed to reverse that correlation in old rats. Peritoneal cells from memantine-treated rats responded differently to phorbol 12-myristate 13-acetate (PMA) – there was an increased dihidrorhodamine fluorescence in all leucokytes, which was abrogated with memantine treatment, and in the old rat group there was a stronger PMA stimulation but reduced inhibitory effect of memantine. Among blood lymphocytes, there was a decreased expression of CD49d (CD43+CD62L+CD49d+), as well as an increased percentage of CD62L+ cells. Finally, while our results show a more pronounced effect of memantine in young rats, we have noticed that old rats under memantine treatment showed signs of nonEAE distress (rough fur, lethargy, respiratory issues). These results show the fast effect of memantine on a systemic level, as well as the potential downsides of its mechanism of action. *The authors marked with an asterisk equally contributed to the work.

InTOR – Repository of the Institute "Torlak" (Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, Serbia)
Good health and well-being
Openalex Percentile: Top 67%
Geochemistry and Geologic Mapping
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.